サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1316891

バイオ医薬品市場：製品タイプ、サービス、原料タイプ、用途別-2023～2030年の世界予測

Biopharmaceuticals Market by Product Type, Services, Raw Material Type, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 190 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
バイオ医薬品市場：製品タイプ、サービス、原料タイプ、用途別-2023～2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオ医薬品の世界市場は、2023年にCAGR 9.67%で5,740億4,000万米ドル、2030年には1兆1,005億1,000万米ドルに達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のバイオ医薬品市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.バイオ医薬品の世界市場規模および予測は？

2.予測期間中、世界のバイオ医薬品市場を形成するCOVID-19の阻害要因と影響は？

3.バイオ医薬品の世界市場において予測期間中に投資すべき製品/セグメント/用途/分野は？

4.バイオ医薬品の世界市場における競争戦略は？

5.バイオ医薬品の世界市場における技術動向と規制の枠組みは？

6.バイオ医薬品の世界市場における主要ベンダーの市場シェアは？

7.バイオ医薬品の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 慢性疾患の蔓延と対象を絞ったバイオ医薬品の必要性
      • ワクチンと医薬品開発への投資の増加
      • バイオ医薬品の魅力的な払い戻しポリシー
    • 抑制要因
      • 原材料のサプライチェーンの混乱と医薬品開発の高コスト
    • 機会
      • バイオ医薬品の製造および試験技術の進歩
      • 生物製剤およびワクチン製造のアウトソーシングの新たな動向
    • 課題
      • 医薬品製造と時間のかかる臨床試験に対する厳格な規制枠組み
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 バイオ医薬品市場：製品タイプ別

  • イントロダクション
  • モノクローナル抗体
  • 精製タンパク質
  • 組換え成長因子
  • 組換えホルモン
  • 組換えタンパク質
  • 合成免疫調節剤
  • ワクチン

第7章 バイオ医薬品市場：サービス別

  • イントロダクション
  • 公定および複数公定の臨床検査
  • カスタムテストまたは顧客独自のテスト
  • 臨床検査

第8章 バイオ医薬品市場：原料タイプ別

  • イントロダクション
  • 医薬品有効成分
  • 製剤添加剤

第9章 バイオ医薬品市場：用途別

  • イントロダクション
  • 自己免疫疾患
  • 心血管疾患
  • ホルモン障害
  • 免疫学
  • 炎症および感染症
  • 代謝障害
  • 神経疾患
  • 腫瘍学

第10章 南北アメリカのバイオ医薬品市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のバイオ医薬品市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのバイオ医薬品市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICALS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICALS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
  • FIGURE 5. BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2022 VS 2030 (%)
  • FIGURE 6. BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2022 VS 2030 (%)
  • FIGURE 7. BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 8. BIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. BIOPHARMACEUTICALS MARKET DYNAMICS
  • FIGURE 10. BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. BIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. BIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. BIOPHARMACEUTICALS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICALS MARKET SIZE, BY PURIFIED PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT HORMONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOPHARMACEUTICALS MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOPHARMACEUTICALS MARKET SIZE, BY SYNTHETIC IMMUNOMODULATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BIOPHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 13. BIOPHARMACEUTICALS MARKET SIZE, BY COMPENDIAL & MULTI COMPENDIAL LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BIOPHARMACEUTICALS MARKET SIZE, BY CUSTOM TESTING OR CUSTOMER PROPRIETARY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BIOPHARMACEUTICALS MARKET SIZE, BY LABORATORY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BIOPHARMACEUTICALS MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. BIOPHARMACEUTICALS MARKET SIZE, BY FORMULATION EXCIPIENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BIOPHARMACEUTICALS MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. BIOPHARMACEUTICALS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. BIOPHARMACEUTICALS MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. BIOPHARMACEUTICALS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. BIOPHARMACEUTICALS MARKET SIZE, BY INFLAMMATORY & INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. BIOPHARMACEUTICALS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. BIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. BIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY RAW MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM BIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. BIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 197. BIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 198. BIOPHARMACEUTICALS MARKET LICENSE & PRICING
目次
Product Code: MRR-434CCDA05137

The Global Biopharmaceuticals Market is forecasted to grow significantly, with a projected USD 574.04 billion in 2023 at a CAGR of 9.67% and expected to reach a staggering USD 1,100.51 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Biopharmaceuticals Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Biopharmaceuticals Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product Type, market is studied across Monoclonal Antibodies, Purified Proteins, Recombinant Growth Factors, Recombinant Hormone, Recombinant Proteins, Synthetic Immunomodulators, and Vaccines. The Recombinant Proteins commanded largest market share of 21.23% in 2022, followed by Vaccines.

Based on Services, market is studied across Compendial & Multi Compendial Laboratory Testing, Custom Testing or Customer Proprietary Testing, and Laboratory Testing. The Custom Testing or Customer Proprietary Testing commanded largest market share of 32.11% in 2022, followed by Laboratory Testing.

Based on Raw Material Type, market is studied across Active Pharmaceutical Ingredient and Formulation Excipients. The Active Pharmaceutical Ingredient commanded largest market share of 77.60% in 2022, followed by Formulation Excipients.

Based on Application, market is studied across Autoimmune Disorders, Cardiovascular Diseases, Hormonal Disorders, Immunology, Inflammatory & Infectious Diseases, Metabolic Disorders, Neurological Diseases, and Oncology. The Inflammatory & Infectious Diseases commanded largest market share of 18.31% in 2022, followed by Neurological Diseases.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 38.89% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Biopharmaceuticals Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biopharmaceuticals Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopharmaceuticals Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopharmaceuticals Market?

4. What is the competitive strategic window for opportunities in the Global Biopharmaceuticals Market?

5. What are the technology trends and regulatory frameworks in the Global Biopharmaceuticals Market?

6. What is the market share of the leading vendors in the Global Biopharmaceuticals Market?

7. What modes and strategic moves are considered suitable for entering the Global Biopharmaceuticals Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biopharmaceuticals Market, by Product Type, 2022 vs 2030
  • 4.3. Biopharmaceuticals Market, by Services, 2022 vs 2030
  • 4.4. Biopharmaceuticals Market, by Raw Material Type, 2022 vs 2030
  • 4.5. Biopharmaceuticals Market, by Application, 2022 vs 2030
  • 4.6. Biopharmaceuticals Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of Chronic Diseases and Need for Targeted Biopharmaceuticals
      • 5.1.1.2. Rising Investments in Vaccine and Drugs Development
      • 5.1.1.3. Attractive Reimbursement Policies for Biopharmaceuticals
    • 5.1.2. Restraints
      • 5.1.2.1. Raw Material Supply Chain Disruptions and High Cost of Drug Development
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in Biopharmaceutical Manufacturing and Testing Technologies
      • 5.1.3.2. Emerging Trends of Outsourcing Biologics and Vaccine Manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent Regulatory Framework for Drug Manufacturing and Time-Consuming Clinical Trials
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Biopharmaceuticals Market, by Product Type

  • 6.1. Introduction
  • 6.2. Monoclonal Antibodies
  • 6.3. Purified Proteins
  • 6.4. Recombinant Growth Factors
  • 6.5. Recombinant Hormone
  • 6.6. Recombinant Proteins
  • 6.7. Synthetic Immunomodulators
  • 6.8. Vaccines

7. Biopharmaceuticals Market, by Services

  • 7.1. Introduction
  • 7.2. Compendial & Multi Compendial Laboratory Testing
  • 7.3. Custom Testing or Customer Proprietary Testing
  • 7.4. Laboratory Testing

8. Biopharmaceuticals Market, by Raw Material Type

  • 8.1. Introduction
  • 8.2. Active Pharmaceutical Ingredient
  • 8.3. Formulation Excipients

9. Biopharmaceuticals Market, by Application

  • 9.1. Introduction
  • 9.2. Autoimmune Disorders
  • 9.3. Cardiovascular Diseases
  • 9.4. Hormonal Disorders
  • 9.5. Immunology
  • 9.6. Inflammatory & Infectious Diseases
  • 9.7. Metabolic Disorders
  • 9.8. Neurological Diseases
  • 9.9. Oncology

10. Americas Biopharmaceuticals Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biopharmaceuticals Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biopharmaceuticals Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing